Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jorge Moreno Herrero"'
Autor:
Yoann Aldon, Paul F. McKay, Jorge Moreno Herrero, Annette B. Vogel, Réka Lévai, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Heinrich Haas, Katalin Fábián, Roger Le Grand, Ugur Sahin, Robin J. Shattock
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 25, Iss , Pp 483-493 (2021)
Self-amplifying mRNA (saRNA) represents a promising platform for nucleic acid delivery of vaccine immunogens. Unlike plasmid DNA, saRNA does not require entry into the nucleus of target cells for expression, having the capacity to drive higher protei
Externí odkaz:
https://doaj.org/article/29be14ddbad34f018d2ece57d78aef2f
Autor:
Heinrich Haas, R. Levai, Roger Le Grand, Yoann Aldon, Annette B. Vogel, Robin J. Shattock, Ugur Sahin, Katalin Fábián, Nathalie Dereuddre-Bosquet, Jorge Moreno Herrero, Paul F. McKay, Pauline Maisonnasse
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 25, Iss, Pp 483-493 (2021)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Self-amplifying mRNA (saRNA) represents a promising platform for nucleic acid delivery of vaccine immunogens. Unlike plasmid DNA, saRNA does not require entry into the nucleus of target cells for expression, having the capacity to drive higher protei
Autor:
Jorge Moreno Herrero, Theo Stahl, Stephanie Erbar, Konrad Maxeiner, Anne Schlegel, Tijana Bacic, Leide Cavalcanti, Martin Schroer, Dmitri Svergun, Ugur Sahin, Heinrich Haas
We introduce aqueous phases comprising single, highly compacted self-amplifying messenger RNA (saRNA) molecules, that are suitable for prophylactic and therapeutic application, specifically for vaccination against infectious diseases. The formulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e41aac1836e3ebecb6a1c15f2a5e1696
https://doi.org/10.21203/rs.3.rs-2142761/v1
https://doi.org/10.21203/rs.3.rs-2142761/v1
Autor:
Verena Krähling, Stephanie Erbar, Alexandra Kupke, Sara S. Nogueira, Kerstin C. Walzer, Hendrik Berger, Erik Dietzel, Sandro Halwe, Cornelius Rohde, Lucie Sauerhering, Letícia Aragão-Santiago, Jorge Moreno Herrero, Sonja Witzel, Heinrich Haas, Stephan Becker, Ugur Sahin
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy.
Emerging and re-emerging viruses, such as Zaire Ebola virus (EBOV), pose a global threat and require immediate countermeasures, including the rapid development of effective vaccines that are easy to manufacture. Synthetic self-amplifying RNAs (saRNAs